Akebia Therapeutics | AKBA - Loan Capital


Akebia Therapeutics reported $24.75M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Akebia Therapeutics USD 24.75M 11.64M Jun/2026
Alnylam Pharmaceuticals USD 2.47B 6.56M Jun/2026
Amgen USD 51.86B 27M Jun/2026
Ardelyx USD 203.52M 683K Mar/2026
Astellas Pharma JPY 320B 0 Jun/2026
AstraZeneca USD 26.01B 46M Jun/2026
Bayer EUR 31.16B 480M Jun/2026
BioMarin Pharmaceutical USD 3.53B 2.1B Jun/2026
Celltrion KRW 411.27B 998.23M Mar/2026
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Fresenius Medical Care EUR 5.82B 83.04M Jun/2026
GlaxoSmithKline GBP 13.95B 65M Jun/2026
Ionis Pharmaceuticals USD 1.91B 6.62M Jun/2026
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
J&J USD 37.34B 183M Jun/2026
Kangmei Pharma CNY 68.57M 9.87M Mar/2026
Karyopharm Therapeutics USD 264.49M 13.73M Mar/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Lexicon Pharmaceuticals USD 49.68M 276K Mar/2026
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Moderna USD 597M 6M Jun/2026
Nektar Therapeutics USD 60.27M 2.89M Mar/2026
Organigram Holdings CAD 60.76M 1.77M Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 32.13M 1.04M Jun/2026
Prothena USD 0 0 Dec/2024
PTC Therapeutics USD 535.52M 248.58M Jun/2026
Qiagen NV USD 1.63B 19.45M Jun/2026
Regeneron Pharmaceuticals USD 1.99B 400K Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 14.65B 806M Jun/2026
Sarepta Therapeutics USD 847.62M 9.46M Jun/2026
Sartorius EUR 3.65B 311.1M Jun/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Tectonic Therapeutic USD 17K 26K Mar/2026
Tilray USD 268.59M 3.82M Sep/2025
Vanda Pharmaceuticals USD 3.15M 3.15M Dec/2024
Zealand Pharma A/S 307M 76.14M Mar/2026
Zz Pientze Pharmaceu CNY 172.8M 9.49M Jun/2026